Core Viewpoint - The article discusses the molecular mechanisms of touch sensation, focusing on the PIEZO gene family and its role in mechanosensation, particularly the unique properties of PIEZO2 as a specialized sensor for tactile stimuli [2][4][20]. Group 1: Molecular Mechanisms of Touch - The PIEZO gene family encodes mechanosensitive ion channels (PIEZO1 and PIEZO2) that convert mechanical signals into electrical or chemical signals, playing a crucial role in various sensory modalities [2][4]. - PIEZO2 mutations can lead to significant mechanosensory defects and neurological diseases, highlighting the importance of understanding its function and structure [3][20]. Group 2: Structural and Functional Differences - PIEZO1 and PIEZO2 are structurally similar but functionally distinct; PIEZO1 is sensitive to various mechanical stimuli, while PIEZO2 specifically detects cellular indentation [8][10]. - PIEZO2 exhibits a unique rigidity in its structure compared to PIEZO1, which may explain its higher sensitivity to indentation stimuli and lower sensitivity to membrane tension [12][13]. Group 3: Mechanism of Force Selectivity - The research identifies filamin-B (FLNB) as a critical anchor connecting PIEZO2 to the actin cytoskeleton, enhancing its sensitivity to localized mechanical forces [14][15]. - A "tethered coupling membrane gating" model is proposed, where PIEZO2's connection to the cytoskeleton allows for efficient force transmission, making it highly sensitive to indentation while being less responsive to uniform membrane tension [15][20]. Group 4: Physiological Relevance and Applications - The co-expression of PIEZO2 and FLNB in sensory neurons suggests a physiological basis for their interaction, with implications for understanding touch and vibration sensation [18][19]. - Abnormal PIEZO2 function is linked to various human diseases, and targeting the PIEZO2-FLNB interaction could lead to new therapeutic strategies for sensory disorders and pain management [20][22].

Core Viewpoint - The research led by Nobel laureate Ardem Patapoutian identifies PIEZO2 as a crucial regulator of renin in the renin-angiotensin-aldosterone system (RAAS), linking it to blood pressure regulation and fluid homeostasis [1][18]. Group 1: Importance of Renin and RAAS - Renin acts as the "start button" for the RAAS, which regulates blood pressure by triggering a series of reactions that lead to vasoconstriction and retention of water and sodium [5]. - The malfunction of this system is closely associated with diseases such as hypertension and heart failure, yet the identity of the pressure sensor in juxtaglomerular cells has remained a mystery for decades [5][19]. Group 2: Identification of PIEZO2 - The research focuses on the PIEZO ion channel family, known for converting mechanical forces into electrochemical signals, with PIEZO2 being abundant in juxtaglomerular cells [7]. - The study confirms that PIEZO2 is likely the long-sought pressure sensor in the kidneys, as its expression is significantly higher in renin-producing cells compared to its counterpart PIEZO1 [7][6]. Group 3: Experimental Findings - Mice lacking PIEZO2 exhibited significantly elevated renin levels, indicating that PIEZO2 functions as a "brake" to prevent excessive renin release under normal conditions [9][8]. - The absence of PIEZO2 disrupted calcium ion oscillations in juxtaglomerular cells, which are essential for regulating renin synthesis and release [11][10]. Group 4: Impact on Renal Function - Mice without PIEZO2 showed increased glomerular filtration rates, likely due to elevated renin activating the ACE2/Ang(1-7)/MAS compensatory pathway, which dilates blood vessels [14][13]. - The study highlights PIEZO2's role as a "faithful sentinel" of blood volume, effectively regulating renin release in response to changes in blood pressure [16][15]. Group 5: Scientific and Clinical Implications - This research resolves a fundamental physiological question regarding renal pressure sensing and establishes a link between PIEZO channels and the RAAS [18][19]. - The findings provide new insights into the pathophysiology of hypertension and heart failure, suggesting that targeting PIEZO2 could lead to novel treatments for cardiovascular and renal diseases [20].